140 related articles for article (PubMed ID: 1457525)
1. Modulation of chemotherapy antineoplastic agents with biologic agents: enhancement of antitumor activities by interleukin-1.
Johnson CS
Curr Opin Oncol; 1992 Dec; 4(6):1108-15. PubMed ID: 1457525
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects.
Veltri S; Smith JW
Stem Cells; 1996 Mar; 14(2):164-76. PubMed ID: 8991536
[TBL] [Abstract][Full Text] [Related]
3. Biologic agents as modifiers of chemotherapeutic effects.
Parmiani G; Rivoltini L
Curr Opin Oncol; 1991 Dec; 3(6):1078-86. PubMed ID: 1843110
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1: biological effects in human hematopoiesis.
Crown J; Jakubowski A; Gabrilove J
Leuk Lymphoma; 1993 Apr; 9(6):433-40. PubMed ID: 8339049
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
Estrov Z; Kurzrock R; Talpaz M
Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1: therapeutic potential for solid tumors.
Johnson CS
Cancer Invest; 1993; 11(5):600-8. PubMed ID: 8402228
[No Abstract] [Full Text] [Related]
8. Synergistic effects between recombinant interleukin-2 and the synthetic immunomodulator murabutide: selective enhancement of cytokine release and potentiation of antitumor activity.
Bahr GM; Darcissac E; Pouillart PR; Chedid LA
J Interferon Cytokine Res; 1996 Feb; 16(2):169-78. PubMed ID: 8742370
[TBL] [Abstract][Full Text] [Related]
9. Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferon.
Wadler S; Schwartz EL
Cancer Chemother Pharmacol; 1994; 35(1):21-30. PubMed ID: 7527304
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
Wadler S; Schwartz EL
Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
[TBL] [Abstract][Full Text] [Related]
11. Design of combination biotherapy studies: future goals and challenges.
Gilewski TA; Golomb HM
Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 in the treatment of cancer.
Curti BD; Smith JW
Pharmacol Ther; 1995 Mar; 65(3):291-302. PubMed ID: 7644565
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection and therapy of radiation injury with cytokines.
Neta R
Prog Clin Biol Res; 1990; 352():471-8. PubMed ID: 2205873
[TBL] [Abstract][Full Text] [Related]
14. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
15. [Interleukin 1 in host anti-tumor mechanisms].
Minato N
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2105-10. PubMed ID: 3496853
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
Mangi MH; Newland AC
Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
18. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
19. Leukemia cells and the cytokine network: therapeutic prospects.
Moqattash S; Lutton JD
Exp Biol Med (Maywood); 2004 Feb; 229(2):121-37. PubMed ID: 14734791
[TBL] [Abstract][Full Text] [Related]
20. Biologic and immunologic therapies for ovarian cancer.
Berek JS; Schultes BC; Nicodemus CF
J Clin Oncol; 2003 May; 21(10 Suppl):168s-174s. PubMed ID: 12743131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
